Read-through Therapy

Read-Through Therapy is a therapeutic strategy in molecular medicine that functions as a pharmacological intervention designed to induce ribosomal read-through of premature termination codons in mutant mRNA transcripts, thereby enabling the production of full-length functional proteins in genetic disorders such as Epidermolysis Bullosa.

22

Publications

1.2K

Citations

174

Authors

75

Institutions

Publications per year

2017–2026

12

Variants

Read-through PharmacotherapyStop-codon Read-through Therapy

Authors

174

  1. KN
    Kerstin Nagel‐Wolfrum

    Johannes Gutenberg University Mainz, Germany

    4 publications · 175 citations

    4

    h-index

  2. DM
    Dillon M. Voss

    Case Western Reserve University, United States

    2 publications · 50 citations

    2

    h-index

  3. LY
    Lucia Yang

    Cold Spring Harbor Laboratory, United States

    2 publications · 50 citations

    2

    h-index

  4. AR
    Adrian R. Krainer

    Cold Spring Harbor Laboratory, United States

    2 publications · 50 citations

    2

    h-index

  5. AS
    A. Samanta

    University Hospitals of Leicester NHS Trust, United Kingdom

    2 publications · 53 citations

    2

    h-index

1–5 of 174

Venues

  1. International Journal of Molecular Sciences

    IJMS · 3 publications · 73 citations

    3

    h-index

  2. Proceedings of the National Academy of Sciences

    PNAS · 2 publications · 199 citations

    2

    h-index

  3. Clinical and Experimental Pediatrics

    CEP · 1 publications · 25 citations

    1

    h-index

  4. Preprints.org

    Repository · 1 publications · 13 citations

    1

    h-index

  5. PLoS Biology

    1 publications · 136 citations

    1

    h-index

1–5